600750 江中药业
已收盘 12-15 15:00:00
资讯
新帖
简况
江中药业更名,华润医药的并购后遗症与增长焦虑
经理人 · 12-15 16:09
江中药业更名,华润医药的并购后遗症与增长焦虑
江中药业独立董事候选人王金本声明符合任职资格
中金财经 · 12-13 19:08
江中药业独立董事候选人王金本声明符合任职资格
江中药业(600750)披露召开2025年第二次临时股东大会通知,12月12日股价上涨0.12%
证券之星 · 12-12
江中药业(600750)披露召开2025年第二次临时股东大会通知,12月12日股价上涨0.12%
江中药业最新公告:拟变更证券简称为“华润江中”
证券之星 · 12-12
江中药业最新公告:拟变更证券简称为“华润江中”
江中药业计划更名为中国资源江中药业有限公司
美股速递 · 12-12
江中药业计划更名为中国资源江中药业有限公司
江中药业(600750)139.29万股限售股将于12月1日解禁,占总股本0.22%
证券之星 · 12-01
江中药业(600750)139.29万股限售股将于12月1日解禁,占总股本0.22%
江中药业(600750)披露2021年限制性股票激励计划首次授予部分第三个解除限售期解锁暨上市公告,11月24日股价下跌0.14%
证券之星 · 11-24
江中药业(600750)披露2021年限制性股票激励计划首次授予部分第三个解除限售期解锁暨上市公告,11月24日股价下跌0.14%
每周股票复盘:江中药业(600750)审计团队变更不影响公司年报工作
证券之星 · 11-23
每周股票复盘:江中药业(600750)审计团队变更不影响公司年报工作
江中药业(600750)披露变更审计项目合伙人、签字会计师及质量控制复核人,11月18日股价上涨0.36%
证券之星 · 11-18
江中药业(600750)披露变更审计项目合伙人、签字会计师及质量控制复核人,11月18日股价上涨0.36%
每周股票复盘:江中药业(600750)OTC业务平稳、精诚徽药协同推进
证券之星 · 11-02
每周股票复盘:江中药业(600750)OTC业务平稳、精诚徽药协同推进
【机构调研记录】恒生前海基金调研江中药业、彩讯股份等3只个股(附名单)
证券之星 · 10-30
【机构调研记录】恒生前海基金调研江中药业、彩讯股份等3只个股(附名单)
股市必读:江中药业(600750)10月29日披露最新机构调研信息
证券之星 · 10-30
股市必读:江中药业(600750)10月29日披露最新机构调研信息
股市必读:江中药业(600750)股东户数4.19万户,较上期增加7.29%
证券之星 · 10-27
股市必读:江中药业(600750)股东户数4.19万户,较上期增加7.29%
江中药业(600750)2025年三季报简析:净利润同比增长5.54%
证券之星 · 10-26
江中药业(600750)2025年三季报简析:净利润同比增长5.54%
江中药业(600750)披露2025年第三季度报告,10月24日股价下跌0.73%
证券之星 · 10-24
江中药业(600750)披露2025年第三季度报告,10月24日股价下跌0.73%
华润系收购版图再扩张:江中药业高溢价收购精诚徽药
21世纪经济报道 · 10-22
华润系收购版图再扩张:江中药业高溢价收购精诚徽药
10月21日江中药业发布公告,股东增持6.02万股
证券之星 · 10-21
10月21日江中药业发布公告,股东增持6.02万股
每周股票复盘:江中药业(600750)拟收购精诚徽药70%股权
证券之星 · 09-28
每周股票复盘:江中药业(600750)拟收购精诚徽药70%股权
江中药业最新公告:拟收购精诚徽药70%股权
证券之星 · 09-26
江中药业最新公告:拟收购精诚徽药70%股权
每周股票复盘:江中药业(600750)2025年第一次临时股东大会召开
证券之星 · 09-14
每周股票复盘:江中药业(600750)2025年第一次临时股东大会召开
加载更多
公司概况
公司名称:
江中药业股份有限公司
所属行业:
医药制造业
上市日期:
1996-09-23
主营业务:
江中药业股份有限公司的主营业务是药品和大健康产品的生产、研发与销售。公司的主要产品是健胃消食片、乳酸菌素片、双歧杆菌三联活菌肠溶胶囊、川贝枇杷胶囊、牛黄蛇胆川贝液、复方瓜子金颗粒、肾宝胶囊、排石颗粒、黄芪生脉饮、八珍益母胶囊、珍菊降压片。江中牌健胃消食片连续二十一年获“中国非处方药产品榜”中成药·消化类第一名;江中利活牌乳酸菌素片荣获2024-2025年度中国药品零售市场畅销品牌、2025年乌镇健康大会“西湖奖·最受药店欢迎的明星单品”等荣誉。
发行价格:
6.80
{"stockData":{"symbol":"600750","market":"SH","secType":"STK","nameCN":"江中药业","latestPrice":24.32,"timestamp":1765782000000,"preClose":24.38,"halted":0,"volume":10280041,"delay":0,"changeRate":-0.0025,"floatShares":629000000,"shares":635000000,"eps":1.3187,"marketStatus":"已收盘","change":-0.06,"latestTime":"12-15 15:00:00","open":24.28,"high":24.48,"low":23.9,"amount":250000000,"amplitude":0.0238,"askPrice":24.33,"askSize":22,"bidPrice":24.32,"bidSize":24,"shortable":0,"etf":0,"ttmEps":1.3187,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"adjPreClose":24.38,"symbolType":"stock","openAndCloseTimeList":[[1765762200000,1765769400000],[1765774800000,1765782000000]],"highLimit":26.82,"lowLimit":21.94,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":634953289,"isCdr":false,"pbRate":4.07,"roa":"--","peRate":18.442405,"roe":"17.03%","epsLYR":1.25,"committee":0.109677,"marketValue":15442000000,"turnoverRate":0.0164,"status":1,"floatMarketCap":15290000000},"requestUrl":"/m/hq/s/600750","defaultTab":"news","newsList":[{"id":"2591561984","title":"江中药业更名,华润医药的并购后遗症与增长焦虑","url":"https://stock-news.laohu8.com/highlight/detail?id=2591561984","media":"经理人","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591561984?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:09","pubTimestamp":1765786140,"startTime":"0","endTime":"0","summary":"对当下的华润医药而言,其核心任务已从追求版图扩张的“冠名”,转向关乎生存模式的内核“重塑”。作者|吴三畏题图|文轩图库文/文轩观察12月12日,江中药业(600750.SH)公告,拟将公司名称变 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251215/c673208915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0175","BK0028","600750","BK0188","BK0239"],"gpt_icon":0},{"id":"2591632882","title":"江中药业独立董事候选人王金本声明符合任职资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2591632882","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591632882?lang=zh_cn&edition=full","pubTime":"2025-12-13 19:08","pubTimestamp":1765624085,"startTime":"0","endTime":"0","summary":"中访网数据 江中药业股份有限公司于近日披露了第十届董事会独立董事候选人王金本的声明与承诺文件。文件显示,王金本已接受公司控股股东华润江中制药集团有限责任公司的提名,并声明其完全符合相关法律法规及公司章程规定的独立董事任职资格。 此外,王金本承诺其在境内上市公司兼任独立董事的数量未超过三家,且在江中药业的连续任职将不超过六年。此次独立董事候选人的声明,标志着江中药业公司治理结构的调整进入关键阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251213/31864419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0028","600750","BK0188","BK0175"],"gpt_icon":0},{"id":"2590502347","title":"江中药业(600750)披露召开2025年第二次临时股东大会通知,12月12日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590502347","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590502347?lang=zh_cn&edition=full","pubTime":"2025-12-12 22:23","pubTimestamp":1765549404,"startTime":"0","endTime":"0","summary":"截至2025年12月12日收盘,江中药业报收于24.38元,较前一交易日上涨0.12%,最新总市值为154.8亿元。该股当日开盘24.34元,最高24.7元,最低24.02元,成交额达7.31亿元,换手率为4.77%。近日,江中药业发布关于召开2025年第二次临时股东大会的通知。公告显示,公司将于2025年12月29日召开2025年第二次临时股东大会,会议将采用现场投票与网络投票相结合的方式进行,网络投票通过上海证券交易所系统开展。股权登记日为2025年12月24日,登记时间为12月25日至26日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200041741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","600750","BK0028","BK0239"],"gpt_icon":0},{"id":"2590577138","title":"江中药业最新公告:拟变更证券简称为“华润江中”","url":"https://stock-news.laohu8.com/highlight/detail?id=2590577138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590577138?lang=zh_cn&edition=full","pubTime":"2025-12-12 18:01","pubTimestamp":1765533676,"startTime":"0","endTime":"0","summary":"江中药业(600750.SH)公告称,公司拟将中文名称变更为“华润江中药业股份有限公司”,英文名称变更为“China Resources Jiangzhong Pharmaceutical Co., Ltd”,证券简称变更为“华润江中”,证券代码保持不变。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200029319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0175","BK0188","600750","BK0239","161027"],"gpt_icon":0},{"id":"1144350907","title":"江中药业计划更名为中国资源江中药业有限公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1144350907","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144350907?lang=zh_cn&edition=full","pubTime":"2025-12-12 17:56","pubTimestamp":1765533369,"startTime":"0","endTime":"0","summary":"江中药业表示,计划将公司名称更改为中国资源江中药业有限公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0188","600750","BK0239","BK0175"],"gpt_icon":0},{"id":"2588871953","title":"江中药业(600750)139.29万股限售股将于12月1日解禁,占总股本0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588871953","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588871953?lang=zh_cn&edition=full","pubTime":"2025-12-01 08:02","pubTimestamp":1764547364,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,江中药业于12月1日将有139.29万股限售股份解禁,为公司股权激励限售股份,占公司总股本0.22%。最近一年内,该股累计解禁171.83万股,占总股本的0.27%。本次解禁后,公司还有626.79万股限售股份,占总股本0.99%。江中药业主营业务:药品和大健康产品的生产、研发与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100000311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","BK0028","600750","BK0239"],"gpt_icon":0},{"id":"2585498519","title":"江中药业(600750)披露2021年限制性股票激励计划首次授予部分第三个解除限售期解锁暨上市公告,11月24日股价下跌0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585498519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585498519?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:24","pubTimestamp":1763994299,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘,江中药业报收于21.61元,较前一交易日下跌0.14%,最新总市值为137.21亿元。该股当日开盘21.71元,最高21.83元,最低21.56元,成交额达8094.33万元,换手率为0.6%。公司近日发布公告称,江中药业股份有限公司2021年限制性股票激励计划首次授予部分第三个解除限售期解除限售条件已成就。本次符合解除限售条件的激励对象共70名,可解除限售的限制性股票数量为1,392,949股,占公司总股本的0.22%。本次解除限售的限制性股票上市流通日期为2025年12月1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400035835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750","BK0239","BK0175","BK0028","BK0188"],"gpt_icon":0},{"id":"2585105369","title":"每周股票复盘:江中药业(600750)审计团队变更不影响公司年报工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2585105369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585105369?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:22","pubTimestamp":1763839334,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘,江中药业报收于21.64元,较上周的22.02元下跌1.73%。本周,江中药业11月18日盘中最高价报22.21元。江中药业当前最新总市值137.4亿元,在中药板块市值排名16/67,在两市A股市值排名1321/5167。公司公告汇总江中药业股份有限公司于2025年11月19日发布公告,因工作调整,毕马威华振会计师事务所变更公司2025年度审计项目合伙人、签字注册会计师及质量控制复核人。本次变更不会对公司2025年度财务报告及内部控制审计工作产生不利影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0239","600750","BK0175"],"gpt_icon":0},{"id":"2584955595","title":"江中药业(600750)披露变更审计项目合伙人、签字会计师及质量控制复核人,11月18日股价上涨0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584955595","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584955595?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:28","pubTimestamp":1763476112,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘,江中药业报收于22.0元,较前一交易日上涨0.36%,最新总市值为139.69亿元。该股当日开盘21.95元,最高22.21元,最低21.89元,成交额达1.09亿元,换手率为0.79%。公司近日发布公告称,因工作调整,毕马威华振会计师事务所将变更公司2025年度审计项目合伙人、签字注册会计师及质量控制复核人。本次变更不会对公司2025年度财务报告及内部控制审计工作产生不利影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800040008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","BK0239","600750","BK0028"],"gpt_icon":0},{"id":"2580383405","title":"每周股票复盘:江中药业(600750)OTC业务平稳、精诚徽药协同推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2580383405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580383405?lang=zh_cn&edition=full","pubTime":"2025-11-02 10:12","pubTimestamp":1762049534,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘,江中药业报收于21.38元,较上周的21.64元下跌1.2%。本周,江中药业10月27日盘中最高价报21.68元。江中药业当前最新总市值135.75亿元,在中药板块市值排名16/67,在两市A股市值排名1410/5163。来自公司公告汇总:江中药业拟回购注销42,733股限制性股票,预计2025年10月30日完成注销。机构调研要点2025年前三季度,公司OTC业务核心品种销售保持整体平稳,库存维持在良性水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750","BK0188","BK0028","BK0239","BK0175"],"gpt_icon":0},{"id":"2579156487","title":"【机构调研记录】恒生前海基金调研江中药业、彩讯股份等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579156487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579156487?lang=zh_cn&edition=full","pubTime":"2025-10-30 08:06","pubTimestamp":1761782810,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月29日披露的机构调研信息,恒生前海基金近期对3家上市公司进行了调研,相关名单如下:1)江中药业 调研纪要:2025年前三季度,公司OTC业务核心品种销售平稳,库存良性,零售终端销售有所改善。毛利率及费用投入预计整体保持稳定。恒生前海基金成立于2016年,截至目前,资产管理规模180.8亿元,排名127/211;资产管理规模180.8亿元,排名109/211;管理公募基金数59只,排名97/211;旗下公募基金经理7人,排名124/211。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000008550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0175","BK0188","300634","600750","BK0239","BK0231"],"gpt_icon":0},{"id":"2579513073","title":"股市必读:江中药业(600750)10月29日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2579513073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579513073?lang=zh_cn&edition=full","pubTime":"2025-10-30 06:28","pubTimestamp":1761776926,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘,江中药业报收于21.39元,上涨0.05%,换手率0.45%,成交量2.81万手,成交额6013.34万元。机构调研要点2025年前三季度,公司OTC业务核心品种销售整体平稳,库存处于良性水平;零售终端处于结构调整深化期,部分终端销售有所改善。外延并购聚焦中药及OTC优势品类,关注女性、儿童健康领域中高市占率或具特色的产品标的,精诚徽药项目已落地。海斯制药金匠产业园现代工厂项目一期预计2025年底建成,2026年投产并逐步释放贝飞达产能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000005691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600750","BK0175","BK0188","BK0239"],"gpt_icon":0},{"id":"2578663519","title":"股市必读:江中药业(600750)股东户数4.19万户,较上期增加7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578663519","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578663519?lang=zh_cn&edition=full","pubTime":"2025-10-27 06:42","pubTimestamp":1761518533,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,江中药业报收于21.64元,下跌0.73%,换手率0.58%,成交量3.62万手,成交额7851.88万元。股本股东变化股东户数变动截至2025年9月30日,江中药业股东户数为4.19万户,较6月30日增加2843户,增幅7.29%。归属于上市公司股东的所有者权益:37.96亿元,同比下降1.74%。酒类业务营收491.15万元,同比下降34.17%,毛利率83.21%,同比减少3.15个百分点。健康消费品及其他营收3.36亿元,同比增长35.06%,毛利率40.04%,同比增加2.91个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700001891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750","BK0188","BK0028","BK0239","BK0175"],"gpt_icon":0},{"id":"2578827683","title":"江中药业(600750)2025年三季报简析:净利润同比增长5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578827683","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578827683?lang=zh_cn&edition=full","pubTime":"2025-10-26 06:02","pubTimestamp":1761429759,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期江中药业发布2025年三季报。根据财报显示,江中药业净利润同比增长5.54%。截至本报告期末,公司营业总收入29.33亿元,同比下降6.28%,归母净利润6.83亿元,同比上升5.54%。按单季度数据看,第三季度营业总收入7.92亿元,同比下降7.59%,第三季度归母净利润1.61亿元,同比上升4.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750"],"gpt_icon":0},{"id":"2577105295","title":"江中药业(600750)披露2025年第三季度报告,10月24日股价下跌0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577105295","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577105295?lang=zh_cn&edition=full","pubTime":"2025-10-24 22:38","pubTimestamp":1761316702,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,江中药业报收于21.64元,较前一交易日下跌0.73%,最新总市值为137.41亿元。近日,江中药业发布2025年第三季度报告。公告显示,公司年初至报告期末实现营业收入2,933,172,225.19元,较上年同期下降6.28%;归属于上市公司股东的净利润为683,450,042.89元,同比增长5.54%。主营业务方面,医药工业板块实现营业收入2,924,512,641.33元,同比下降5.58%;酒类业务收入为4,911,543.65元,同比下降34.17%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400043068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","BK0028","600750","BK0239"],"gpt_icon":0},{"id":"2577738687","title":"华润系收购版图再扩张:江中药业高溢价收购精诚徽药","url":"https://stock-news.laohu8.com/highlight/detail?id=2577738687","media":"21世纪经济报道","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577738687?lang=zh_cn&edition=full","pubTime":"2025-10-22 07:00","pubTimestamp":1761087600,"startTime":"0","endTime":"0","summary":"华润系在医药领域的整合步伐持续加快。近日,华润旗下江中药业宣布,已与蚌埠投资集团签署股权转让协议,以7078.393万元收购安徽省精诚徽药70%股权,交易完成后将获得其实际控制权并纳入合并报表。此次收购的一大焦点是高溢价。转让公告显示,精诚徽药净资产为4198.24万元,但评估价值高达10111.99万元,评估增值率达140.86%。精诚徽药成立于2013年11月,虽为小型企业,但具备“高新技术企业”“专精特新中小企业”资质,核心聚焦中药补益类OTC产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-10-22/doc-infutfvx8313598.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-10-22/doc-infutfvx8313598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0239","BK0028","600750","BK0175"],"gpt_icon":0},{"id":"2577749708","title":"10月21日江中药业发布公告,股东增持6.02万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2577749708","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577749708?lang=zh_cn&edition=full","pubTime":"2025-10-21 23:00","pubTimestamp":1761058851,"startTime":"0","endTime":"0","summary":"证券之星消息,10月21日江中药业发布公告《江中药业:江中药业关于控股股东增持股份结果的公告》,其股东华润江中制药集团有限责任公司于2025年9月18日至2025年10月21日间合计增持6.02万股,占公司目前总股本的0.0095%,变动期间该股股价下跌1.32%,截止10月21日收盘报21.61元。股东增减持详情见下表:根据江中药业2025年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100037319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","BK0028","600750","BK0239"],"gpt_icon":0},{"id":"2570889167","title":"每周股票复盘:江中药业(600750)拟收购精诚徽药70%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2570889167","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570889167?lang=zh_cn&edition=full","pubTime":"2025-09-28 02:59","pubTimestamp":1758999549,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘,江中药业报收于21.8元,较上周的21.6元上涨0.93%。本周,江中药业9月24日盘中最高价报21.9元。江中药业当前最新总市值138.43亿元,在中药板块市值排名16/67,在两市A股市值排名1366/5157。本周关注点公司公告汇总:江中药业拟以不高于7,078.393万元收购精诚徽药70%股权。公司公告汇总:江中药业2025年半年度每股派发现金红利0.5元(含税),股权登记日为2025年10月10日。江中药业第十届董事会第八次会议于2025年9月25日召开,审议通过多项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800000709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750","BK0175","BK0239","BK0028","BK0188"],"gpt_icon":0},{"id":"2570012670","title":"江中药业最新公告:拟收购精诚徽药70%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2570012670","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570012670?lang=zh_cn&edition=full","pubTime":"2025-09-26 18:01","pubTimestamp":1758880895,"startTime":"0","endTime":"0","summary":"江中药业(600750.SH)公告称,公司第十届董事会第八次会议审议通过关于拟收购安徽省精诚徽药药业有限公司70%股权的议案,以自有资金通过公开摘牌方式进行,成交价格不高于7078.393万元。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092600029216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750","BK0188","BK0028","BK0239","BK0175"],"gpt_icon":0},{"id":"2567113666","title":"每周股票复盘:江中药业(600750)2025年第一次临时股东大会召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2567113666","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567113666?lang=zh_cn&edition=full","pubTime":"2025-09-14 04:48","pubTimestamp":1757796492,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘,江中药业报收于21.92元,较上周的21.86元上涨0.27%。本周,江中药业9月12日盘中最高价报22.11元。本周关注点公司公告汇总:江中药业2025年第一次临时股东大会于2025年9月8日召开,审议通过利润分配及续聘审计机构议案。出席股东及代理人共908名,代表股份301,753,931股,占公司总股本47.5206%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0175","BK0188","600750"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765839595472,"stockEarnings":[{"period":"1week","weight":0.0524},{"period":"1month","weight":0.1045},{"period":"3month","weight":0.1398},{"period":"6month","weight":0.1238},{"period":"1year","weight":0.2211},{"period":"ytd","weight":0.1307}],"compareEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":-0.0307},{"period":"3month","weight":0.0016},{"period":"6month","weight":0.1414},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.154}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江中药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41856人(较上一季度增加7.29%)","perCapita":"15020股","listingDate":"1996-09-23","address":"江西省南昌市青山湖区高新区火炬大道788号","registeredCapital":"63495万元","survey":" 江中药业股份有限公司的主营业务是药品和大健康产品的生产、研发与销售。公司的主要产品是健胃消食片、乳酸菌素片、双歧杆菌三联活菌肠溶胶囊、川贝枇杷胶囊、牛黄蛇胆川贝液、复方瓜子金颗粒、肾宝胶囊、排石颗粒、黄芪生脉饮、八珍益母胶囊、珍菊降压片。江中牌健胃消食片连续二十一年获“中国非处方药产品榜”中成药·消化类第一名;江中利活牌乳酸菌素片荣获2024-2025年度中国药品零售市场畅销品牌、2025年乌镇健康大会“西湖奖·最受药店欢迎的明星单品”等荣誉。","listedPrice":6.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"江中药业(600750)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供江中药业(600750)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"江中药业,600750,江中药业股票,江中药业股票老虎,江中药业股票老虎国际,江中药业行情,江中药业股票行情,江中药业股价,江中药业股市,江中药业股票价格,江中药业股票交易,江中药业股票购买,江中药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"江中药业(600750)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供江中药业(600750)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}